DAY 2 |
15 October, 2013 |
08:00 |
Welcome Coffee Desk & Registration |
08:45 |
SESSION II: Personalized Medicine in Oncology
Chairs:
- Guy Berchem, CHL & CRP-Santé, Luxembourg.
- Olga Golubnitschaja, Professor, Department of Radiology, University of Bonn, Germany & European Association for Predictive, Preventive and Personalised Medicine, Belgium.
Speakers:
- Gottfried Köhler, CEO, OnkoTec GmbH, Max F. Perutz Laboratories, University of Vienna, Austria.
Title: ”Non-Invasive approach to urinary bladder cancer screening and recurrence”
- Cees Winnips, Medical Director Europe, Myriad Genetics, Zürich, Switzerland.
Title: “Translation of an “old” clinical phenomenon in to an innovative treatment for malignant tumor complications: the development history of LTA-T”
- Godefridus Peters, Department of Medical Oncology, VU University Medical Center, Amsterdam, Netherlands.
Title: “Determinants of the efficacy of tyrosine kinase inhibitors: uptake, metabolism and/or the target?”
- Nicholas J. Sarlis, Vice President and Head of Medical Affairs, Incyte Corporation, Wilmington, USA.
Title: ”Pitfalls and Solutions in Translational Medicine: Some Examples from Translational Oncology
|
10:05 |
Coffee Break and Visit of Sponsors’ Booths |
10:45 |
SESSION III: New Horizons in Biomarkers
- Chairs:
Catherine Larue, CEO, Integrated BioBank of Luxembourg.
- Nicholas J. Sarlis, Vice President and Head of Medical Affairs, Incyte Corporation, Wilmington, USA.
SPEAKERS
- Ivo Gut, Director, National Genome Analysis Centre (CNAG), Spain.
Title: “The Genomic and Epigenomic Landscape of Cancer Biomarkers”
- Philippe Ancian, Senior Director, Vectorology & Biomarkers, Transgene, France.
Title: ”R&D applications of biomarkers” to “Development of Two Companion Diagnostics (CDx) for a Therapeutic Vaccine for Lung Cancer”
- Ulrich Pfeffer, Director, National Cancer Research Institute – IST Genova, Italy.
Title: ”Validation with gene expression data of proposed prostate cancer biomarkers: a long road to travel”
|
12:25 |
Lunch and Visit of Sponsors’ Booths |
12:25 |
Press Conference |
13:30 |
SESSION IV: Disease Modelling and EpidemiologyChairs:
- Michael N. Liebman, Managing Director, Strategic Medicine, Inc, & IPQ Analytics, LLC, USA.
- Simone Niclou, Head of Norlux Laboratory, CRP-Santé, Luxembourg.
Speakers:
- Erfan Younesi, Fraunhofer Institute for Algorithms and Scientific Computing SCAI, Department of Bioinformatics, Sankt Augustin, Germany.
Title: ”Knowledge-based Integrative Disease Modeling in Support of Translational Research”
- Hugo Geerts, Chief Operating Officer, In-Silico Biosciences, Adj Associate Professor, Perelman School of Medicine, University of Pennsylvania, USA.
Title: “Using Quantitative Systems Pharmacology for de-risking projects in Alzheimer’s R&D”
- Michael N. Liebman, Managing Director, Strategic Medicine, Inc, & IPQ Analytics, LLC, USA.
Title: ”Modeling Disease Processes: From Diagnosis and Staging to Clinical Decision Support”
|
14:30 |
Coffee Break and Visit of Sponsors’ Booths |
15:00 |
SESSION V: Public Health and Translational MedicineChairs:
- Fay Betsou, Chief Biospecimen Science/President of ISBER, IBBL, Luxembourg.
- Denis Lacombe, Director, EORTC, Belgium.
Speakers:
- Wei Wang, Professor, School of Medical Sciences, Edith Cowan University, Australia & School of Public Health and Family Medicine, Capital Medical University, Beijing, China.
Title: ”Suboptimal Health: A Potential Preventive Instrument For Non-Communicable Disease Control and Management”
- Jes S. Lindholt, Professor, Elitary Research Centre of Individualised Medicine in Arterial Diseases (CIMA) Department of Cardiovascular- and Thoracic Surgery T, University Hospital of Odense, Odense, Denmark.
Title: ”Beta-blocker Use and Clinical Outcomes after Primary Vascular Surgery: A Nationwide Propensity Score-Matched Study”
- Olga Golubnitschaja, Professor, Department of Radiology, University of Bonn, Germany & European Association for Predicitive, Preventive and Personalised Medicine, Belgium.
Title: “The central role of laboratory medicine as the integrating element in healthcare services – global statements of the European Association for Predictive, Preventive and Personalised Medicine”
|
16:00 |
SESSION VI: New Horizons in ImmunologyChairs:
- Fengmin Zhang, Dean, Basic Medical Science School, Harbin Medical University, China.
- François Hentges, Head of Immunogenetics and Allergology Laboratory, CRP-Santé, Luxembourg.
Speakers:
- Thomas Stoehr, Head Translational Medicine, Ablynx, Belgium.
Title: ”Development of an antibody for inhalational therapy of RSV infection in children: design of a strategy to translate from animal studies into first in infant clinical trials”
- Alexandra Zanin-Zhorov, Senior Director Immunology, Kadmon Research Institute, New York, USA.
Title: “Selective oral ROCK2 inhibitor down-regulates IL-21 and IL-17 secretion in human T cells”
- Fengmin Zhang, Dean, Basic Medical Science School, Harbin Medical University, China.
Title: ”The value of decreased plasma gelsolin titers in patients with systemic lupus erythematosus and rheumatic arthritis in diagnosis and disease activity evaluation”
|
17:00 |
SESSION VII: EUSTM Expert Panels Showcase SessionChair:
- Randall J Cohrs, Professor, School of Medicine, University of Colorado, Denver, USA & Vice President, European Society for Translational Medicine (EUSTM).
Speaker:
- Ernesto Oviedo-Orta, Clinical Sciences Expert, Novartis Vaccines and Diagnostics, Siena, Italy.
Title: ”Vaccines Development for non noncommunicable diseases-Translational Research Prospectives”
- Antonio Facchiano, Professor, IDI-IRCCS, Istituto Dermopatico dell’Immacolata, Rome, Italy.
Title: ”Novel diagnostic approaches to early non-invasive diagnosis: experience on melanoma and tumoral vessel growth”
- Mauro Magnani, Professor, Department of Biomolecular Sciences, University of Urbino & EryDel SpA, Italy.
Title: ”Red Blood Cells-mediated delivery of corticosteroid analogues in Ataxia Telangiectasia: clinical studies and mechanism(s) of action”
- István Jánosi, Managing Director, Planimeter Kft, Budapest Hungary.
Title: ”Exploration and Description of Ophthalmology Studies Based on ClinicalTrials.gov Database”
|
18:30 |
Inauguration Ceremony:The Academy of Translational Medicine |
19:00 |
Cocktail for Conference Participants & Poster Viewing |